The Journey of Primary Myelofibrosis to Splenic Marginal Zone Lymphoma on the Wheels of Ruxolitinib.
作者信息
Dass Jasmita, Langer Sabina, Kotwal Jyoti, Gupta Nitin
机构信息
Hematopathology, Sir Ganga Ram Hospital, New Delhi, India.
Clinical Hematology and Bone Marrow Stem Cell Transplant, Sir Ganga Ram Hospital, New Delhi, India.
出版信息
Indian J Hematol Blood Transfus. 2021 Jan;37(1):186-188. doi: 10.1007/s12288-020-01320-w. Epub 2020 Jul 16.
Abstract
摘要
相似文献
1
The Journey of Primary Myelofibrosis to Splenic Marginal Zone Lymphoma on the Wheels of Ruxolitinib.芦可替尼驱动下原发性骨髓纤维化向脾边缘区淋巴瘤的转变历程
Indian J Hematol Blood Transfus. 2021 Jan;37(1):186-188. doi: 10.1007/s12288-020-01320-w. Epub 2020 Jul 16.
2
Splenic marginal zone lymphoma presenting as myelofibrosis associated with bone marrow involvement of lymphoma cells which secrete a large amount of TGF-beta.脾边缘区淋巴瘤表现为骨髓纤维化，伴有分泌大量转化生长因子β的淋巴瘤细胞浸润骨髓。
Ann Hematol. 2004 May;83(5):322-5. doi: 10.1007/s00277-003-0806-y. Epub 2003 Nov 11.
3
Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis.伴显著骨髓纤维化的脾边缘区淋巴瘤，酷似三阴性原发性骨髓纤维化。
Case Rep Oncol. 2019 Nov 1;12(3):834-837. doi: 10.1159/000504129. eCollection 2019 Sep-Dec.
4
5
NF-κB deregulation in splenic marginal zone lymphoma.脾脏边缘区淋巴瘤中 NF-κB 的失调。
Semin Cancer Biol. 2016 Aug;39:61-7. doi: 10.1016/j.semcancer.2016.08.002. Epub 2016 Aug 5.
6
CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.CD5 表达鉴定出具有更高淋巴细胞增多的脾边缘区淋巴瘤亚群：24 例临床病理、细胞遗传学和分子研究。
Haematologica. 2010 Apr;95(4):604-12. doi: 10.3324/haematol.2009.011049. Epub 2009 Dec 16.
7
Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas.结外、淋巴结及脾边缘区淋巴瘤中API2-MALT1融合易位的发生率及亚型特异性
Am J Pathol. 2000 Apr;156(4):1183-8. doi: 10.1016/S0002-9440(10)64988-7.
8
Primary nodal marginal zone lymphomas of splenic and MALT type.脾脏和MALT型原发性淋巴结边缘区淋巴瘤。
Am J Surg Pathol. 1999 Jan;23(1):59-68. doi: 10.1097/00000478-199901000-00006.
9
Follicular lymphoma with involvement of the splenic marginal zone: a pitfall in the differential diagnosis of splenic marginal zone cell lymphoma.
Hum Pathol. 1996 May;27(5):503-6. doi: 10.1016/s0046-8177(96)90093-3.
10
Blastic transformation of splenic marginal zone B-cell lymphoma.脾边缘区B细胞淋巴瘤的原始细胞转化
Arch Pathol Lab Med. 2000 May;124(5):748-52. doi: 10.5858/2000-124-0748-BTOSMZ.
引用本文的文献
1
Exploring the molecular mechanisms between lymphoma and myelofibrosis.探索淋巴瘤与骨髓纤维化之间的分子机制。
Am J Transl Res. 2024 Mar 15;16(3):730-737. doi: 10.62347/NWJO7078. eCollection 2024.
本文引用的文献
1
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms.芦可替尼治疗与骨髓增殖性肿瘤中B细胞淋巴瘤的风险
Am J Hematol. 2019 Jul;94(7):E185-E188. doi: 10.1002/ajh.25489. Epub 2019 May 1.
2
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.接受 JAK1/2 抑制剂治疗的骨髓纤维化患者中的侵袭性 B 细胞淋巴瘤。
Blood. 2018 Aug 16;132(7):694-706. doi: 10.1182/blood-2017-10-810739. Epub 2018 Jun 14.
Zotero 插件